Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

May 31, 2027

Study Completion Date

June 30, 2027

Conditions
Alopecia Areata
Interventions
DRUG

CTP-543

Twice daily dosing

Trial Locations (91)

10029

Icahn School of Medicine at Mount Sinai, New York

10075

Sadick Research Group, New York

14620

UR Dermatology at College Town, Rochester

15241

Peak Research - Pennsylvania, Upper Saint Clair

19104

Hospital of the University of Pennsylvania Dept of Dermatology, Philadelphia

19462

Dermatology Associates of Plymouth Meeting, Plymouth Meeting

22903

University of Virginia Health System, Charlottesville

23233

West End Dermatology Associates, Richmond

27104

Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem

27617

North Carolina Dermatology Associates, PLLC, Raleigh

28211

Dermatology Specialists of Charlotte, Charlotte

28277

Darst Dermatology, Charlotte

29407

Clinical Research Center of the Carolinas, Charleston

29644

Palmetto Clinical Trial Services, Fountain Inn

33021

Skin Care Research, LLC, Hollywood

33125

University of Miami Hospital, Miami

33172

Lenus Research & Medical Group, LLC, Sweetwater

33179

Floridian Research Institute, LLC, Miami

33486

Skin Care Research, LLC, Boca Raton

33607

Clinical Research Trials of Florida, Inc., Tampa

33613

ForCare Clinical Research, Tampa

35203

Total Skin and Beauty Dermatology Center, Birmingham

40241

DS Research, Louisville

42301

Qualmedica Research, Owensboro

43209

Bexley Dermatology Research, Bexley

43215

Remington-Davis, Inc., Columbus

46168

The Indiana Clinical Trials Center, PC, Plainfield

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

47150

DS Research, New Albany

48038

Clinical Research Institute of Michigan, Clinton Township

48346

Clarkston Skin Research, Clarkston

53144

Clinical Investigation Specialists, Inc., Kenosha

55417

University of Minnesota Department of Dermatology, Minneapolis

55432

Minnesota Clinical Study Center, Fridley

60611

Denova Research, Chicago

72758

Northwest Arkansas Clinical Trials Center, PLLC, Rogers

72916

Johnson Dermatology, Fort Smith

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

75034

North Texas Center for Clinical Research, Frisco

75230

Dermatology Treatment and Research Center - Dallas, Dallas

77056

Suzanne Bruce and Associates, PA, Houston

78213

Progressive Clinical Research, San Antonio

78218

Texas Dermatology and Laser Specialists, San Antonio

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

78660

Austin Institute for Clinical Research, Inc., Pflugerville

80111

Colorado Center for Dermatology, PLLC d/b/a CODerm Research, Centennial

80210

Colorado Medical Research Center, Denver

83702

ASR, LLC, Boise

84088

Jordan Valley Dermatology, West Jordan

85032

Alliance Dermatology & MOHS Center, Phoenix

85260

Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale

89119

Vivida Dermatology, Las Vegas

90045

Dermatology Research Associates, Los Angeles

91303

Hope Clinical Research, Canoga Park

91324

Quest Dermatology Research, Northridge

92024

California Dermatology & Clinical Research Institute, Encinitas

92262

Palmtree Clinical Research, Inc., Palm Springs

92697

University of California, Irvine, Irvine

93301

Kern Research Inc., Bakersfield

94063

Stanford University School of Medicine - Medical Dermatology Clinic, Redwood City

94118

Kaiser Permanente Clinical Trials Unit, San Francisco

94611

Kaiser Permanente Northern California - Oakland, Oakland

95823

Kaiser Permanente South Sacramento, Sacramento

97201

Oregon Medical Research Center, Portland

97210

NW Dermatology Institute, Portland

06519

Yale University Church Street Research Unit, New Haven

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

07601

Skin Laser and Surgery Specialists of NJ, Hackensack

07044

Schweiger Dermatology, P.C., Verona

02818

Velocity Clinical Research-Providence, East Greenwich

02903

Rhode Island Hospital, Providence

T1Y 0B4

Dermatology Research Institute, Calgary

T2G 1B1

Kirk Barber Research, Calgary

T4P 1K4

Care Clinic, Red Deer

V1Y 4N7

Medical Arts Health Research Group, Kelowna

V3V 0C6

Enverus Medical Research, Surrey

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

M8X 1Y9

Kingsway Clinical Research, Etobicoke

N1L 0B7

Guelph Dermatology Research, Guelph

N6H 5L5

DermEffects, London

L3P 1X3

Lynderm Research Inc., Markham

L3Y 5G8

Dr. S. K. Siddha Medicine Professional Corporation, Newmarket

L6J 7W5

The Centre for Clinical Trials, Oakville

K1K 4L2

JRB research Inc., Ottawa

L4B 1A5

Centre for Dermatology, Richmond Hill

M4W 2N4

Research Toronto, Toronto

N2J 1C4

Alliance Clinical Trials, Waterloo

H2X 2V1

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Québec

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT03898479 - Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata | Biotech Hunter | Biotech Hunter